These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11289796)

  • 21. Control of murine cytomegalovirus in the lungs: relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates.
    Holtappels R; Podlech J; Geginat G; Steffens HP; Thomas D; Reddehase MJ
    J Virol; 1998 Sep; 72(9):7201-12. PubMed ID: 9696814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus inhibition of extrinsic apoptosis determines fitness and resistance to cytotoxic CD8 T cells.
    Chaudhry MZ; Casalegno-Garduno R; Sitnik KM; Kasmapour B; Pulm AK; Brizic I; Eiz-Vesper B; Moosmann A; Jonjic S; Mocarski ES; Cicin-Sain L
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12961-12968. PubMed ID: 32444487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Techniques for studying murine natural killer cells in defense against viral infection.
    Scalzo AA; Farrell HE; Karupiah G
    Methods Mol Biol; 2000; 121():163-77. PubMed ID: 10818725
    [No Abstract]   [Full Text] [Related]  

  • 24. The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion.
    Kavanagh DG; Gold MC; Wagner M; Koszinowski UH; Hill AB
    J Exp Med; 2001 Oct; 194(7):967-78. PubMed ID: 11581318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coordinated function of murine cytomegalovirus genes completely inhibits CTL lysis.
    Pinto AK; Munks MW; Koszinowski UH; Hill AB
    J Immunol; 2006 Sep; 177(5):3225-34. PubMed ID: 16920962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Processing and presentation of murine cytomegalovirus pORFm164-derived peptide in fibroblasts in the face of all viral immunosubversive early gene functions.
    Holtappels R; Grzimek NK; Simon CO; Thomas D; Dreis D; Reddehase MJ
    J Virol; 2002 Jun; 76(12):6044-53. PubMed ID: 12021337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Murine cytomegalovirus m02 gene family protects against natural killer cell-mediated immune surveillance.
    Oliveira SA; Park SH; Lee P; Bendelac A; Shenk TE
    J Virol; 2002 Jan; 76(2):885-94. PubMed ID: 11752177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Murine cytomegalovirus homologues of cellular immunomodulatory genes.
    Davis-Poynter NJ; Degli-Esposti M; Farrell HE
    Intervirology; 1999; 42(5-6):331-41. PubMed ID: 10702715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamics of killer T cell inflation in viral infections.
    Wodarz D; Sierro S; Klenerman P
    J R Soc Interface; 2007 Jun; 4(14):533-43. PubMed ID: 17251133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How viruses hide from T cells.
    McMichael A
    Trends Microbiol; 1997 Jun; 5(6):211-2; discussion 212-3. PubMed ID: 9211637
    [No Abstract]   [Full Text] [Related]  

  • 31. Effective inhibition of K(b)- and D(b)-restricted antigen presentation in primary macrophages by murine cytomegalovirus.
    LoPiccolo DM; Gold MC; Kavanagh DG; Wagner M; Koszinowski UH; Hill AB
    J Virol; 2003 Jan; 77(1):301-8. PubMed ID: 12477835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strength in Numbers: Visualizing CTL-Mediated Killing In Vivo.
    Nolz JC; Hill AB
    Immunity; 2016 Feb; 44(2):207-8. PubMed ID: 26885849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of antiviral CTL responses by virus-infected cells: line item veto (cells) revisited.
    Rich RF; Green WR
    Virology; 2000 Jul; 272(2):237-43. PubMed ID: 10873766
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of programmed cell death by cytomegaloviruses.
    Brune W
    Virus Res; 2011 May; 157(2):144-50. PubMed ID: 20969904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Host defense mechanism in virus infections].
    Mori R
    Rinsho Byori; 1986 Jan; 34(1):26-30. PubMed ID: 3009923
    [No Abstract]   [Full Text] [Related]  

  • 36. The pathogenicity of cytomegalovirus.
    Sweet C
    FEMS Microbiol Rev; 1999 Jul; 23(4):457-82. PubMed ID: 10422262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced cytomegalovirus infection of developing brain independent of the adaptive immune system.
    van den Pol AN; Reuter JD; Santarelli JG
    J Virol; 2002 Sep; 76(17):8842-54. PubMed ID: 12163604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced CTL response and increased viral burden in substance P receptor-deficient mice infected with murine gamma-herpesvirus 68.
    Elsawa SF; Taylor W; Petty CC; Marriott I; Weinstock JV; Bost KL
    J Immunol; 2003 Mar; 170(5):2605-12. PubMed ID: 12594288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytomegalovirus impairs antiviral CD8+ T cell immunity by recruiting inflammatory monocytes.
    Daley-Bauer LP; Wynn GM; Mocarski ES
    Immunity; 2012 Jul; 37(1):122-33. PubMed ID: 22840843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mast cells expedite control of pulmonary murine cytomegalovirus infection by enhancing the recruitment of protective CD8 T cells to the lungs.
    Ebert S; Becker M; Lemmermann NA; Büttner JK; Michel A; Taube C; Podlech J; Böhm V; Freitag K; Thomas D; Holtappels R; Reddehase MJ; Stassen M
    PLoS Pathog; 2014 Apr; 10(4):e1004100. PubMed ID: 24763809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.